Article info
PDFOriginal research
Informing critical care drug requirements in response to the COVID-19 pandemic
- Correspondence to Anita Hogg, Medicines Optimisation Innovation Centre, Northern Health and Social Care Trust, Antrim BT41 2RL, UK; anita.hogg{at}northerntrust.hscni.net
Citation
Informing critical care drug requirements in response to the COVID-19 pandemic
Publication history
- Received May 14, 2020
- Revised June 3, 2020
- Accepted June 8, 2020
- First published July 13, 2020.
Online issue publication
November 23, 2020
Article Versions
- Previous version (21 November 2020).
- Previous version (21 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.